Positive results advance peanut tablet to phase II development
ALK’s peanut tablet shown to be safe and tolerable across multiple doses.Development now advances to phase II for dose finding...
Staff
Tessera Therapeutics Receives Investment to Develop Curative In Vivo Genetic Treatment for Sickle Cell Disease
Investments of up to $50 million from the Bill & Melinda Gates Foundation to develop globally accessible in vivo genetic...
Polyrizon’s Moving Forward with Expected 2025 Clinical Trial – Entered Manufacturing Agreement for its PL-14 Allergy Blocker
The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer...
Vireo Growth Inc. Announces $75 Million Financing and Acquisitions of Four Single State Operators
– $75 million equity financing at $0.625 per Vireo share will result in combined new entity having an industry-leading balance...
The Ensign Group Agrees to Add Its First Operations in Alaska and Oregon And Announces Expansion in Washington and California
SAN JUAN CAPISTRANO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group...
Bioplastics: Paving the Way to Meet EU Packaging and Packaging Waste Regulation Goals
BRUSSELS, Dec. 18, 2024 (GLOBE NEWSWIRE) -- European Bioplastics (EUBP) welcomes the adoption of the European Union’s ambitious Packaging and...
ENA Respiratory Announces Peer-Reviewed Publication of First Time in Humans and Influenza Virus Challenge Studies with the Intranasal Innate Immunomodulator INNA-051
When compared to placebo, prophylactic administration of INNA-051 was associated with significantly increased expression of multiple host defense genes and...
Johnson & Johnson submits application to the European Medicines Agency seeking approval of a new indication for IMBRUVICA® (ibrutinib) in adult patients with previously untreated mantle cell lymphoma (MCL) who are eligible for autologous stem cell transplant
The European MCL Network Phase 3 TRIANGLE study, evaluated ibrutinib in combination with induction immunochemotherapy, both with and without an...
Vandria announces first subjects dosed in its first-in-human Phase 1 clinical trial of VNA-318 brain-penetrant mitophagy inducer
LAUSANNE, Switzerland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Vandria SA, a company at the vanguard of mitochondrial therapeutics developing first-in-class...
Therma Bright Signs LOI For U.S. Distribution Network Expansion For Venowave With DME Authority
Initiative Includes Milestone-Based Inventory Purchase Commitments During Q1 and Q2, 2025Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Therma Bright...
Compliancy Group is G2’s Winter 2024 Leader for Healthcare Compliance Software
NEW YORK, Dec. 18, 2024 /PRNewswire/ -- Compliancy Group has been awarded as G2's Winter Leader for Healthcare Compliance Software....
Plansight, Inc. Successfully Completes Type 2 SOC 2 Examination with an Unqualified Opinion
Plansight, Inc. Reports on Security and Privacy Standards Established by The American Institute of Certified Public Accountants (AICPA) for its...
Safe Supply Streaming Co. Ltd. Announces Board Member Resignation
Toronto, Ontario--(Newsfile Corp. - December 17, 2024) - Safe Supply Streaming Co. Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe...
CHAMPIONING MENTAL HEALTH FOR NCAA STUDENT-ATHLETES: LG ELECTRONICS CONCLUDES 3RD SEASON OF ‘TRANSPARENT CONVERSATIONS’ PODCAST
The latest episodes focus on the importance of mental health resources for the next generation of collegiate athletes ENGLEWOOD CLIFFS,...
ISS National Lab-Sponsored Projects on Cancer, Neurodegenerative Conditions, and More Return From Space Station
Nearly 50 payloads safely splashed down to Earth on SpaceX's 31st Commercial Resupply Services Mission for NASA KENNEDY SPACE CENTER, Fla.,...
Radin Health’s All-in-One Radiology Workflow Management Solution Receives Overwhelming Response at RSNA 2024
SHERIDAN, Wyo., and AVENTURA, Fla., Dec. 17, 2024 /PRNewswire/ -- Radin Health, a leading provider of advanced radiology AI-Powered solutions, proudly...
CLR Neurosthenics® launches neurophysiological assessment platform to help prevent sports injuries, optimize performance and improve rehabilitation
LOS ANGELES, Dec. 17, 2024 /PRNewswire/ -- Sports and recreational injuries send more than 3.5 million Americans to the hospital...
Forbes Recognizes Kroger as a Leader in Workplace Culture and Pharmacy Customer Service
CINCINNATI, Dec. 17, 2024 /PRNewswire/ -- The Kroger Co. (NYSE:KR), America's Grocer, today announced its Forbes recognition as one of America's...
Brook.ai Wins Merit Award for AI-Powered Remote Care Management Platform
Cited for innovation in pioneering a new model of chronic disease management that blends AI technology with human expertise. SEATTLE,...
BRAIN.ONE Brain Fitness Platform Announces Strategic Partnership with Acclaimed Thought Leader Tim Storey and Global Recovery Advocate Darren Prince
ASPEN, Colo., Dec. 17, 2024 /PRNewswire/ -- BRAIN.ONE, a groundbreaking personalized brain fitness platform, is pleased to announce a partnership...